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Abstract
Binary (nucleotide-protein dimer and hexamer complexes) and ternary (nucleotide-protein-inhibitor complexes) p97 
complexes were subjected to molecular dynamics simulations in an attempt to further our understanding of the p97 
protein oligomer domain stability and, more importantly, of the recently reported diverse molecular mechanisms of 
inhibition including allosteric, ATP-competitive and covalent inhibitors. Analysis of stable states following equilibra-
tion phases indicated a higher intrinsic stability of the homohexamer as opposed to the dimer, and of N-D1 domains as 
opposed to the D2 domain. The molecular dynamics of the proposed allosteric binding model reproduced important 
molecular interactions identified experimentally with high frequency throughout the trajectory. Observed conforma-
tional changes occurring in the D2 nucleotide binding site provided a novel bind-rearrange-react hypothesis of stepwise 
molecular events involved in the specific covalent inhibitor mode of action.
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1. Introduction
The AAA+ (ATPases Associated with diverse cellular 
Activities) protein family carries out multiple functions, 
including chromatin decondensation, homotypic mem-
brane fusion and ubiquitin dependent protein degradation 
by the proteasome. In particular, p97, or Valosine-contain-
ing Protein (VCP), is a 97 kDa protein belonging to the 
AAA+ protein family. p97 includes two copies of a nucleo-
tide-binding domain, called D1 and D2 which are inter-
connected by a 20 amino-acids long loop (the D1-D2 
linker) and preceded by a non-nucleotide binding domain, 
the N-domain, which is oriented outward to permit inter-
action with adapter proteins.1
p97 regulates a number of processes involving ubiq-
uitin, due to its ability to segregate ubiquitinated substrates 
from unmodified partners. In particular, p97 plays an es-
sential role in the ubiquitin-dependent proteasomal degra-
dation, including endoplasmic reticulum-associated degra-
dation (ERAD),2,3 degradation of some cytosolic proteins 
by the ubiquitin-fusion domain (UFD) pathway4 and rapid 
degradation of nascent peptides during heat shock.5
Crystallographic studies of p976 testify that it func-
tions as a homo-hexameric ring, formed by the D1 and D2 
domains with the N-terminal domain oriented outward to 
permit interaction with adapter proteins. The formation of 
this complex molecular machinery is driven by pro-
tein-protein interactions (PPIs). 
In recent works,7–9 small molecules able to inhibit 
p97 were identified (Figure 1a). Different mechanisms of 
inhibition were proposed for these molecules. NMS-873 
seems to act as an allosteric inhibitor of p97, binding in 
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close proximity to the N-terminal of the D1-D2 linker. 
NMS-322 is a ATP competitor and binds in the nucleotide 
binding site in D2. Finally, NMS-859 is a covalent inhibitor 
that binds to Cys522. However, there is a lack of structural 
models rationalizing these postulated binding modes. In 
this work we employ computational techniques to investi-
gate the binding mode of these inhibitors both from the 
conformational and energetical point of view. Molecular 
dynamics simulations were carried out on these systems 
and a subsequent computational alanine scanning allowed 
us to identify the fundamental residues for the binding of 
these compounds. The aforementioned technique has 
been extensively used to map, from the energetic point of 
view, the interaction pattern of protein in complex with 
small ligands both of peptidic10 and non-peptidic11 nature. 
In the case of the allosteric inhibitor (NMS-873) the need 
of a good starting structure for molecular dynamics simu-
lations prompted us to employ molecular docking. It is 
well proven in literature, indeed, that molecular docking 
studies on biological systems can successfully predict the 
structures of intermolecular complexes formed by ligands 
and their receptors (ranging from proteins12 to DNA13). 
2. Materials and Methods
The reference p97 structure was obtained from the 
Protein Data Bank (PDB ID code: 3CF1).The VCP hexam-
er, the relevant biological assembly according to the au-
thors of the original paper1 (as well as an analysis per-
formed with the software PISA14), was derived from 
standard symmetry operations in PyMOL.15 The missing 
residues in the D2 domain were rebuilt using the software 
Modeller 9v7.16 Molecular dynamics simulations were car-
ried out with Gromacs 4.5.317 using the Amber ff99SB18 
force field for the protein and the Generalized Amber 
Force Field (GAFF)19 for the inhibitors and nucleotides. 
The complexes were solvated with TIP3P20 waters and 
neutralized with sodium ions.
The molecular systems studied were first subjected to 
a steepest descent minimization run (10000 steps) with al-
pha carbons constrained by a force constant of 1000 kJ 
mol–1 nm–2. Subsequently, an equilibration of 200 ps was 
performed under NVT conditions at 310 K using the v-res-
cale thermostat21 with a time constant of 0.1 ps. Electrostat-
ic interactions were treated with the Particle Mesh Ewald 
(PME)22 algorithm using a 10 Å cutoff. All bonds were con-
strained using the LINCS23 algorithm, allowing a 2 fs time-
step. A further 200 ps equilibration run was performed un-
der NPT conditions at 310 K and 1 atm using the Berendsen 
barostat method24 with a 0.5 ps correlation time. Alpha 
carbons were kept constrained as above. A 20 ns produc-
tion run followed at constant temperature and pressure (1 
atm, 310 K), releasing the constraints on the alpha carbons.
In order to clarify relative importance of amino acid 
residues and their interactions, computational alanine 
scanning and free energy calculations were performed us-
ing the Molecular Mechanics Generalized Born Surface 
Area (MM-GBSA) approach25 on snapshots extracted at 
20 ps intervals from the last 10 ns of the trajectories (500 
snapshots in total) once the systems reached equilibrium. 
A 0.15 M NaCl solution was simulated as the solvent. The 
entropic contribution to the free energy data was neglect-
ed in the free energy calculations used in this study mainly 
due to the lack of reliability of results for the molecular 
systems considered here. An extended discussion on this 
topic can be found in literature.26–30 
The starting structures of the complexes containing 
the inhibitor molecules NMS-873, NMS-322 and NMS-
859 (non covalently bound, see discussion) were generated 
by molecular docking with QXP v0705 program31 setting 
the following parameters to the mcdock tool: in house 
modified QXP MacroModel forcefield, 1500 Monte Carlo 
steps saving 20 poses for visual inspection. The rather large 
number of poses saved enabled a procedure identifying 
orientations compatible with photo-affinity labeling ex-
perimental evidence reported by Magnaghi et al., 2013.7 
Candidate binding sites were studied in order to identify 
pockets suitable for hosting inhibitor substituents. Ac-
cording to standard modeling procedures, binding site 
side chains were scrutinized in order to address protona-
tion and 180° rotations of crystallographically equivalent 
groups and correct eventual atomic overlap. Subsequently, 
all structures were subject to the pre-simulation and simu-
lation phases described above. 
The Cys522/NMS-859 covalently bound structure 
was prepared as follows. As the p97 crystal structure shows 
the side chain of Cys522 (covalent bond site) completely 
buried, the dynamical behaviour of the Walker A loop was 
evaluated with a 20 ns long MD simulation of the apo hex-
amer protein to verify if a suitable conformation of Cys522 
side chain exists for the reaction with NMS-859. The 
change in the surface accessible area of Cys522 was moni-
tored and, interestingly, Cys522 was found to protrude 
into the ATP binding site in a solvent accessible conforma-
tion during the simulation. The protomer showing the 
highest solvent accessible area for Cys522 was extracted 
with its adjacent protomer and a relevant structural model 
of NMS-859 covalently bound to the Cys522 side chain 
was obtained building the Cys522/NMS-859 bond.
A more energetically meaningful structure was sought 
for by subjecting this new model to 100 simulated annealing 
runs, raising the temperature to 600 K and then cooling 
down to 0 K. Even at high temperatures, NMS-859 did not 
undergo any major rearrangements within the binding site. 
A reference structure was obtained by performing a cluster 
analysis on the 100 final structures of the simulated anneal-
ing and choosing the central element of the most populated 
cluster. The structure resulting from the cluster analysis was 
used to generate the hexamer with a NMS-859 molecule 
bound in each of the D2 ATP binding sites. The hexamer 
was subsequently submitted to a 20 ns MD simulation.
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3. Results and Discussion
A series of molecular dynamics simulations was per-
formed on a p97 hexamer model in complex with NMS-
873, NMS-322 and NMS-859 (Figure 1). Before doing so, 
we compared results from simulations performed on di-
meric vs hexameric forms of p97 without inhibitors. The 
use of a dimeric in the place of the hexameric model con-
stituted a significant advantage in terms of CPU-time re-
quired for these calculations. However, results from the 
test simulations excluded this possibility due to severe mo-
lecular instability observed with the dimer. Specifically, 
unlike the hexameric system, the p97 dimer suffered a 
gradual but complete detachment of the D2 domain from 
the D1 domain within the same protomer in the early stag-
es of the production run. Such a dramatic rearrangement 
would interfere with the simulation of our set of ligands, 
which bind regions at the intra- and inter-protomer inter-
faces.
The allosteric binding site and NMS-873. NMS-873 
was originally docked into a putative binding site that was 
subsequently confirmed by photo-affinity labeling experi-
ments. Depending on the position of reactive groups on 
NMS-873 analogues, Lys615 and Asn616 were specifically 
targeted as previously reported.11 The model was further 
refined according to the procedure in the material and 
methods section. The selected pose involved, among other 
pockets, the lateral tunnel leading to the central pore of the 
hexamer between the D1 and D2 domains of two adjacent 
protomers. On the basis of observed kinetics, a stoichiom-
etry of 1:2 was applied with one molecule bound to the 
A–B, C–D and E–F interfaces, respectively.
ΔG and alanine scanning. The three NMS-873 mol-
ecules showed a consistent behaviour throughout the mo-
lecular dynamics run, with a ΔG of binding of –69.2 ± 3.1 
kcal/mol (A–B interface), –67.8 ± 2.7 kcal/mol (C–D in-
terface) and –71.5 ± 2.9 kcal/mol (E–F interface). The co-
herent results for the three molecules are likely to be due to 
the tight packing and good fit of the molecule among resi-
dues and cavities at the D1 and D2 interface of the two 
adjacent protomers. In this case, the use of a hexameric 
model system turned out to be particularly important, 
since the simulation of the dimer would have led to a 
slacker binding site and a progressive weakening of the 
network of interactions due to protomer separation.
Computational alanine scanning highlighted the 
most relevant protein residues involved in the binding of 
this inhibitor. Lys615 showed the highest ΔΔG values on 
average (4.4 kcal/mol) with its contribution consisting of 
both hydrophobic interactions with the biphenyl moiety of 
NMS-873 and the hydrogen bond between the ε-amino 
group and the pyridine moiety of the inhibitor. This partic-
ular hydrogen bond occurred in 20%, 34%, 71% of the 
snapshots in the A–B, C–D, E–F binding sites, respectively. 
The difference was due to the possible torsion of the pyri-
dine moiety with respect to the triazole plane, allowing 
Figure 1.a) Structures of NMS-873, NMS-322 and NMS-859. b) Top view of the p97 hexamer: the single protomers are labelled with letters from A 
to F. c) Lateral view of the p97 hexamer coloured by domains and highlighting the NMS-873 binding site (red rectangle).
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considerable variability in the making and breaking of this 
interaction. The aromatic pyridine ring was also found to 
effectively interact with Gln568 (1.3 kcal/mol) through 
van der Waals contacts.
Gln215 (2.9 kcal/mol), Gln212 (1.0 kcal/mol) and 
Leu456 (1.6 kcal/mol) further stabilized the binding at the 
opposite ends of the molecule through hydrophobic con-
tacts with the cyclopentyl and the methylsulphonyl group. 
Most relevant interactions are shown in Figure 2a.
Other less frequent examples of amino acids that fa-
vourably took part in the binding with NMS-873, showing 
higher ΔΔG values only in specific couples of protomers 
were Arg453 (1.3 kcal/mol, A–B interface) and His406 (2.0 
kcal/mol, B–C interface). Both formed hydrogen bonds 
with the terminal p-methylsulphonyl moiety. Gln458 (1.2 
kcal/mol) and Asn460 (1.7 kcal/mol) participated in stabi-
lizing the biphenyl part of the molecule in the C–D couple. 
Further hydrophobic interactions involved Arg365 (2.0 
kcal/mol, A–B couple) and Lys211 (2.0 kcal/mol, E–F cou-
ple), which make favourable contact with the pyridine and 
the cyclopentyl moieties, respectively.
ATP-competitive inhibitors. NMS-322 belongs to 
the class of compounds sensitive to the ATP concentra-
tion.13 Due to the complex and cooperative enzymatic 
mechanism of p97, it is impossible to distinguish between 
direct ATP competition and a mixed inhibitory mecha-
nism where the binding of the compound affects the bind-
ing affinity of ATP in a different pocket of the hexamer. 
However, also in this case, there is experimental evidence 
of direct interactions within the nucleotide binding site in 
D2, namely the binding of Asp478 with a reactive azido 
analog of NMS-322 (“compound 35”).13
ΔG and alanine scanning. Computational alanine 
scanning was performed to highlight the residues provid-
ing the principal interactions in NMS-322 binding. The 
results identified Thr525, Leu526 and Thr688 as the most 
important residues in all six protomers (Figure 2b). Leu526 
showed the highest average ΔΔG value (2.5 kcal/mol) es-
tablishing hydrophobic interactions with the nitroaniline 
and the cyclohexane moieties of NMS-322. Thr688 (aver-
age ΔΔG of 1.1 kcal/mol) provided further hydrophobic 
interactions, whereas Thr525 (average ΔΔG = 1.3 kcal/
mol) engaged hydrogen bonds with the carboxyl group of 
NMS-322, both through the backbone (44%) and the side-
chain (52%).
Other aminoacids displayed varying ΔΔG values de-
pending on the specific protomer, indicating some free-
dom of translation within this relatively large binding site. 
In particular, a group of residues in common for protomers 
A, B, D and E with cross-protomer interactions was iden-
tified. Only for these protomers, Arg635 showed average 
ΔΔG values of 1.7 kcal/mol, providing interactions with 
the hydrophobic part of NMS-322 and hydrogen bonds 
with the carboxylic moiety. Hydrogen bonding was rela-
tively often observed in protomers A (25% frequency) and 
E (15%). For the same group of NMS-322 molecules, the 
carboxylic substituent frequently made interactions with 
Lys524. The molecules bound to protomer C and F exhib-
ited a slightly different behaviour, extending towards the 
bottom of the ATP pocket, rather than towards the adja-
cent protomer, resulting in null ΔΔG values for Arg635, 
whereas Ile656 and Asn660 had higher ΔΔG values in re-
lation to the above mentioned protomers. Being Thr525, 
Leu526 and Thr688 constantly involved in the interaction 
with the molecule in all protomers, it can be pointed out 
that the shifting between the two poses occurred around 
Thr525, acting as a hinge, with NMS-322 sliding between 
Thr525 and Leu526, allowing a deeper interaction inside 
the pocket or with the residues from the adjacent protomer.
In order to evaluate the NMS-322 displacement in 
the different protomers, the average RMSD on the mole-
cule was calculated, after aligning the D2 domain back-
bone, with respect to the starting structure. The molecules 
bound to protomers A, B, D and E show an average RMSD 
over time of 3.82 Å, 2.92 Å, 3.45 Å and 3.30 Å, respectively, 
whereas the average RMSD rose to 5.93 Å and 4.71 Å for 
the molecules bound to protomers C and F, respectively. 
Despite the higher displacement for the molecule bound 
to protomer C, its ΔG of binding (–47.4 ± 3.8 kcal/mol) 
was consistent with the ΔG calculated for the molecules 
bound to protomers A (–44.4 ± 3.3 kcal/mol), B (–51.8 ± 
3.2 kcal/mol), D (–46.2 ± 3.0 kcal/mol) and E (–53.3 ± 2.7 
kcal/mol). In this case, NMS-322, as already highlighted 
by the alanine scanning results, could replace the original 
interactions with alternative ones, balancing the loss ΔG 
contributions. On the other hand, NMS-322 in protomer F 
was not found to efficiently rearrange to establish new 
binding interactions. Calculated ΔG of binding within 
protomer F and NMS-322 increased to –38.3 kcal/mol.
Covalent and specific class of inhibitors. NMS-859 
is an irreversible protein modifier that was found by mass 
spectroscopy to covalently and specifically bind VCP at an 
active site cysteine. The Cys522 residue belongs to the 
Walker A motif, which is the ATP phosphate binding loop 
of the D2 domain nucleotide binding site. This covalent 
modification has been experimentally shown to totally im-
pair the ATPase activity of the enzyme.
A possible mechanism of action would involve the 
binding of NMS-859 within the ATP binding site on the 
D2 domain, followed by the formation of a covalent bond 
with Cys522. In order to study the first step of the pro-
posed binding process and evaluate the non-covalent fit-
ting with the putative binding site, NMS-859 was docked 
in the D2 domain ATP pocket in the hexameric model 
(stoichiometry 1:1) and simulated for 20 ns. NMS-859 
showed several similarities with NMS-322, primarily a sig-
nificant contribution to the binding by hydrophobic con-
tacts within the ATP site residues and the adjacent 
protomer. Computational alanine scanning performed on 
the last 10 ns of the trajectory highlighted Leu526, with an 
average ΔΔG of 1.6 kcal/mol and Thr688 (ΔΔG = 1.6 kcal/
mol) as hot-spots in all six protomers (Figure 2c). The two 
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residues made up a hydrophobic cluster with the benzothi-
azole and phenyl moieties of NMS-859. Ile656, which was 
identified as a possible partner of interaction for NMS-
322, was also found to contribute to the binding with 
NMS-859 in all the protomers with an average ΔΔG of 2.1 
kcal/mol. The interaction with residues from the adjacent 
protomer also played a key role in the binding, in particu-
lar through Arg635, with an average ΔΔG of 1.1 kcal/mol. 
NMS-859 adopted slightly different poses in the six 
protomers, resulting in ΔG values ranging from –34.4 ± 
2.7 kcal/mol (protomer E) to –44.9 ± 2.0 kcal/mol 
(protomer A), as observed for NMS-322. NMS-859 enters 
the space between Leu526 and Thr688 allowing the mole-
cule to interact more favourably with the hydrophobic res-
idues located at the bottom of the ATP pocket or with 
Arg635 of the adjacent protomer (as observed for NMS-
322). Overall, the ligand showed a good affinity for the 
ATP pocket with the chlorine atom preferentially oriented 
towards the Walker A loop, possibly representing a favour-
able molecular arrangement for the reaction with Cys522.
The structural model of NMS-859 covalently bound 
to the Cys522 sidechain was obtained as described in the 
material and methods section. 
A qualitative analysis of the trajectory highlighted a 
binding pose comparable to non-covalently bound NMS-
859. Obviously, an evaluation of the free energy of binding 
was excluded, given the covalent bonding with the protein. 
The analysis of residues in proximity of NMS-859 high-
lighted some of the same amino acids seen for the un-
bound molecule as possible partners of hydrophobic inter-
actions. In particular, Leu526, Asn660 and Thr688 
remained in close contact with the benzothiazole and phe-
nyl moieties of the molecule throughout the entire length 
of simulations in all six protomers (Figure 2d). Ile656 and 
Ile479 also contributed in stabilizing the binding with the 
benzothiazole part of NMS-859.
In a way similar to NMS-322, the Walker A motif 
provided a series of hydrogen bonds, in particular Lys524 
and Thr525 backbone (41% and 48% of the snapshots, re-
spectively) interacts with the amide group and the sulphur 
of NMS-859. A translation within the pocket, such as ob-
served for the unbound molecule and for NMS-322, is 
also observed in the covalently bound NMS-859, in this 
case occurring by the pivoting of the ligand around 
Cys522. The molecules bound to protomers A and B pre-
served a pose close to the starting conformation, interact-
Figure 2a) NMS-873 in complex with p97. b) NMS-322 in complex with p97. c) NMS-859 in complex with p97. d) NMS-859 covalently bound to 
residue Cys522 of p97. Interaction diagrams of these compounds can be found in Supporting information.
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ing preferentially with residues belonging to the ATP 
pocket. The average RMSD (calculated on the molecule 
after the alignment of the D2 domain) resulted to be 1.04 
Å and 0.83 Å, respectively. In these two cases, Thr688 was 
also favourably oriented to establish a hydrogen bond 
with the amine hydrogen of NMS-859, detected in 33% of 
the snapshots for the molecule bound to protomer A and 
in 35% of the snapshots for the molecule bound to 
protomer B.
For the NMS-859 molecules bound to the protomers 
C to F, a preferential orientation towards Arg635 and 
Pro636 of the adjacent protomer was observed. Here the 
average RMSD with respect to the starting structure were 
2.51 Å in protomer C, 4.21 Å in protomer D, 2.45 Å in 
protomer E and 2.57 Å in protomer F. In these cases, the 
loss of interactions with the inner residues of the ATP 
pocket was presumably balanced by a gain in hydrophobic 
interactions between Arg635 and Pro636 with the phenyl 
and thiomethylene moieties of NMS-859, as highlighted 
for NMS-322.
4. Conclusions
The simulations reported in the study reproduce ex-
perimental observations made for what concerns both 
general aspects of molecular stability of the p97 protein 
and specific molecular interactions with inhibitors. The 
biologically relevant hexameric assembly was more stable 
than the dimer and the most unstable part of the single 
protomer was represented by the D2 domain as observed 
in crystallographic structures and in trypsin protein diges-
tion experiments. Simulations performed on the different 
protein-inhibitor complexes showed good stability and re-
producibility all around the hexamer. In particular, the 
postulated allosteric binding site and the binding mode of 
NMS-873 were surprisingly well conserved throughout 
the MD trajectory and consistently reproduce some of the 
most important interactions observed experimentally. 
Even though the ability to design more potent inhibitors 
remains to be proven, the approach adopted is certainly 
useful in providing a dynamic structural model able to ra-
tionalize a number of experimental observations regard-
ing the mechanism of action of the different classes of p97 
inhibitors reported to date.
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Izvedli smo simulacije molekulske dinamike za binarne (kompleks nukleotid-dimer in heksamer proteina) in ternarne 
(kompleks nukleotid-inhibitor proteina) komplekse proteina p97, da bi razumeli stabilnost domene oligomera p97 in, 
kar je še bolj pomembno, molekularne mehanizme v inhibiciji, vključno z različnimi alosteričnimi, ATP-kompetitivnimi 
in kovalentnimi inhibitorji, o katerih so poročali kratkim. Analiza stabilnih stanj, ki sledijo uravnoteževalnim fazam, je 
pokazala, da je homoheksamer bolj stabilen v primerjavi z dimerom, in hkrati so domene N-D1 bolj stabilne v pirmerjavi 
z domeno D2. Molekulska dinamika predlaganega alosteričnega vezavnega modela reproducira pomembne molekulske 
interakcije, ki so bile ugotovljene eksperimentalno z visoko frekvenco vzdolž trajektorije. Opažene konformacijske spre-
membe, ki se pojavljajo v D2-vezavnem mestu nukleotidov, ponujajo novo hipotezo, imenovano bind-rearrange-react, o 
postopnih molekularnih dogodkih, ki so udeleženi pri specifičnem kovalentnem načinu delovanja inhibitorjev. 
